Diagnosis and treatment of common urinary tract infections.

J. Cimino,L. B. Guze,G. Schreiner

American family physician

Abstract:

What problem does this paper attempt to address?

RAS G-domains Fine-Tune the Sorting of Phosphatidylserine Acyl Chains in the Plasma Membrane

Neha Arora,Hong Liang,Yong Zhou

DOI: https://doi.org/10.1101/2023.06.20.545612

2023-01-01

Abstract:Mutant RAS are major contributors to cancer and signal from nanoclusters on the plasma membrane (PM), via isoform-specific membrane anchors. However, the same RAS isoform bound to different guanine nucleotides are segregated on the PM. Paradoxically, various segregated RAS nanoclusters all enrich a type of anionic phospholipid, phosphatidylserine (PS). These findings suggest intricate participation of RAS G-domains in their PM distribution, which have not been explored. We now show that wild-types, oncogenic G12V mutants and membrane anchors of isoforms HRAS, KRAS4A and KRAS4B sort distinct PS species. Mechanistically, shifting orientation states of KRAS4B G-domain exposes residues, such as Arg 73, Arg 102 and Arg 135, to the PM, and contributes to PS acyl chain sorting. Oncogenic mutations may shift orientation states of G-domains. We show that G12V, G12D, G12C, G13D and Q61H mutants of KRAS4B sort distinct PS species. Thus, RAS G-domains fine-tune their lateral distribution on the PM.### Competing Interest StatementThe authors have declared no competing interest.
RAS G-domains allosterically contribute to the recognition of lipid headgroups and acyl chains

Neha Arora,Huanwen Mu,Hong Liang,Wenting Zhao,Yong Zhou

DOI: https://doi.org/10.1083/jcb.202307121

2024-05-06

Abstract:Mutant RAS are major contributors to cancer and signal primarily from nanoclusters on the plasma membrane (PM). Their C-terminal membrane anchors are main features of membrane association. However, the same RAS isoform bound to different guanine nucleotides spatially segregate. Different RAS nanoclusters all enrich a phospholipid, phosphatidylserine (PS). These findings suggest more complex membrane interactions. Our electron microscopy-spatial analysis shows that wild-types, G12V mutants, and membrane anchors of isoforms HRAS, KRAS4A, and KRAS4B prefer distinct PS species. Mechanistically, reorientation of KRAS4B G-domain exposes distinct residues, such as Arg 135 in orientation state 1 (OS1) and Arg 73/Arg 102 in OS2, to the PM and differentially facilitates the recognition of PS acyl chains. Allele-specific oncogenic mutations of KRAS4B also shift G-domain reorientation equilibrium. Indeed, KRAS4BG12V, KRAS4BG12D, KRAS4BG12C, KRAS4BG13D, and KRAS4BQ61H associate with PM lipids with headgroup and acyl chain specificities. Distribution of these KRAS4B oncogenic mutants favors different nanoscale membrane topography. Thus, RAS G-domains allosterically facilitate membrane lateral distribution.
Implications for Downstream Signaling

Ki-Young Lee

DOI: https://doi.org/10.3390/ijms25052530

IF: 5.6

2024-02-22

International Journal of Molecular Sciences

Abstract:Transient homo-dimerization of the RAS GTPase at the plasma membrane has been shown to promote the mitogen-activated protein kinase (MAPK) signaling pathway essential for cell proliferation and oncogenesis. To date, numerous crystallographic studies have focused on the well-defined GTPase domains of RAS isoforms, which lack the disordered C-terminal membrane anchor, thus providing limited structural insight into membrane-bound RAS molecules. Recently, lipid-bilayer nanodisc platforms and paramagnetic relaxation enhancement (PRE) analyses have revealed several distinct structures of the membrane-anchored homodimers of KRAS, an isoform that is most frequently mutated in human cancers. The KRAS dimerization interface is highly plastic and altered by biologically relevant conditions, including oncogenic mutations, the nucleotide states of the protein, and the lipid composition. Notably, PRE-derived structures of KRAS homodimers on the membrane substantially differ in terms of the relative orientation of the protomers at an "α–α" dimer interface comprising two α4–α5 regions. This interface plasticity along with the altered orientations of KRAS on the membrane impact the accessibility of KRAS to downstream effectors and regulatory proteins. Further, nanodisc platforms used to drive KRAS dimerization can be used to screen potential anticancer drugs that target membrane-bound RAS dimers and probe their structural mechanism of action.

biochemistry & molecular biology,chemistry, multidisciplinary
Ras signaling mechanisms: New insights from single-molecule biophysics

Anne Marie McCombs,Joy R. Armendariz,Joseph J. Falke

DOI: https://doi.org/10.1016/j.bpj.2024.08.025

IF: 3.4

2024-10-02

Biophysical Journal

Abstract:Cellular membranes serve as signaling platforms for a wide array of signaling pathways assembled on plasma or endosomal membranes. In many of these pathways, small GTPases of the Ras superfamily play central roles in specific signaling complexes (1), and live-cell studies reveal that diffusing Ras isoforms exist in two major membrane microenvironments (2,3,4). In vitro single-molecule studies of reconstituted signaling complexes on supported lipid bilayers have become increasingly important in the elucidation of molecular mechanisms by which membrane signaling elements are regulated and transfer information (5,6,7,8,9,10,11,12,13,14,15,16,17).

biophysics
K-Ras G-domain binding with signaling lipid phosphatidylinositol (4,5)-phosphate (PIP2): membrane association, protein orientation, and function

Shufen Cao,Stacey Chung,SoonJeung Kim,Zhenlu Li,Danny Manor,Matthias Buck

DOI: https://doi.org/10.1074/jbc.ra118.004021

IF: 5.485

2019-04-01

Journal of Biological Chemistry

Abstract:Ras genes potently drive human cancers, with mutated <i>proto-oncogene GTPase KRAS4B</i> (<i>K-Ras4B</i>) being the most abundant isoform. Targeted inhibition of oncogenic gene products is considered the "holy grail" of present-day cancer therapy, and recent discoveries of small-molecule KRas4B inhibitors were made thanks to a deeper understanding of the structure and dynamics of this GTPase. Because interactions with biological membranes are key for Ras function, Ras-lipid interactions have become a major focus, especially because such interactions evidently involve both the Ras C terminus for lipid anchoring and its G-protein domain. Here, using NMR spectroscopy and molecular dynamics simulations complemented by biophysical- and cell-biology assays, we investigated the interaction between K-Ras4B with the signaling lipid phosphatidylinositol (4,5)-phosphate (PIP2). We discovered that the β2 and β3 strands as well as helices 4 and 5 of the GTPase G-domain bind to PIP2 and identified the specific residues in these structural elements employed in these interactions, likely occurring in two K-Ras4B orientation states relative to the membrane. Importantly, we found that some of these residues known to be oncogenic when mutated (D47K, D92N, K104M, and D126N) are critical for K-Ras-mediated transformation of fibroblast cells, but do not substantially affect basal and assisted nucleotide hydrolysis and exchange. Moreover, the K104M substitution abolished localization of K-Ras to the plasma membrane. The findings suggest that specific G-domain residues can critically regulate Ras function by mediating interactions with membrane-associated PIP2 lipids; these insights that may inform the future design of therapeutic reagents targeting Ras activity.

biochemistry & molecular biology
Abstract A015: Dynamics and lipid interactions of the RAS-RBD-CRD protein complex

Felice C. Lightstone,Timothy S. Carpenter

DOI: https://doi.org/10.1158/1557-3125.ras23-a015

2023-05-01

Molecular Cancer Research

Abstract:Abstract The high-resolution structure of the RAS G-domain complexed to the RBD and CRD domains of RAF provides critical insights into the assembly and conformation of the RAS-RAF signaling complex[1]. The influence and impact of the membrane on both the RAS and RAF proteins is a factor that we are just beginning to understand and appreciate. Molecular simulation is an ideal methodology to further study the complicated relationship between the membrane and associated proteins. Our recent work, using MuMMI[2] (Multiscale Machine-learned Modeling Infrastructure), investigated the different lipid compositions around KRAS4b and the interplay between the protein behavior and these membrane environments[3]. MuMMI uses machine learning to couple adjacent simulation scales and can be effectively scaled across some of the world’s largest high performance computing systems. The MuMMI multi-resolution framework has been expanded to include the RAF RBD-CRD domains. Here we present the overall simulation results from this latest MuMMI campaign. Tens of thousands of coarse-grained molecular dynamics simulations were completed, sampled from a variety of protein/lipid composition configurations. The orientations of the RAS-RBD-CRD complex on the membrane occupies distinct configurational states. Furthermore, the spatial patterns of lipid arrangements around these different protein states are also unique to each state. Interactions of the CRD with the membrane indicate the enrichment of very specific lipids in precise locations act to stabilize the complex. The extent, and size of the lipid ‘fingerprint’ imposed on the membrane by the RAS-RBD-CRD protein complex is significantly larger than observed for just the RAS protein on its own. We do not observe any statistically significant defined protein-protein orientations within the simulation ensemble. These observations indicate that spatial co-localize the RAS-RBD-CRD proteins in the same vicinity may be assisted by specific membrane environments. [1] Tran, Timothy H., et al. "KRAS interaction with RAF1 RAS-binding domain and cysteine-rich domain provides insights into RAS-mediated RAF activation." Nature communications 12.1 (2021): 1-16. [2] Di Natale, Francesco, et al. "A massively parallel infrastructure for adaptive multiscale simulations: modeling RAS initiation pathway for cancer." Proceedings of the International Conference for High Performance Computing, Networking, Storage and Analysis. 2019. [3] Ingólfsson, Helgi I., et al. "Machine learning–driven multiscale modeling reveals lipid-dependent dynamics of RAS signaling proteins." Proceedings of the National Academy of Sciences 119.1 (2022): e2113297119. Citation Format: Felice C. Lightstone, Timothy S. Carpenter. Dynamics and lipid interactions of the RAS-RBD-CRD protein complex [abstract]. In: Proceedings of the AACR Special Conference: Targeting RAS; 2023 Mar 5-8; Philadelphia, PA. Philadelphia (PA): AACR; Mol Cancer Res 2023;21(5_Suppl):Abstract nr A015.

oncology,cell biology
Biophysical mechanism for Ras-nanocluster formation and signaling in plasma membrane

Thomas Gurry,Ozan Kahramanogullari,Robert G. Endres

DOI: https://doi.org/10.1371/journal.pone.0006148

2009-06-12

Abstract:Ras GTPases are lipid-anchored G proteins which play a fundamental role in cell signaling processes. Electron micrographs of immunogold-labeled Ras have shown that membrane-bound Ras molecules segregate into nanocluster domains. Several models have been developed in attempts to obtain quantitative descriptions of nanocluster formation, but all have relied on assumptions such as a constant, expression-level independent ratio of Ras in clusters to Ras monomers (cluster/monomer ratio). However, this assumption is inconsistent with the law of mass action. Here, we present a biophysical model of Ras clustering based on short-range attraction and long-range repulsion between Ras molecules in the membrane. To test this model, we performed Monte Carlo simulations and compared statistical clustering properties with experimental data. We find that we can recover the experimentally-observed clustering across a range of Ras expression levels, without assuming a constant cluster/monomer ratio or the existence of lipid rafts. In addition, our model makes predictions about the signaling properties of Ras nanoclusters in support of the idea that Ras nanoclusters act as an analog-digital-analog converter for high fidelity signaling.

Subcellular Processes
Divergent Mechanisms Activating RAS and Small GTPases Through Post-translational Modification

Natsuki Osaka,Yoshihisa Hirota,Doshun Ito,Yoshiki Ikeda,Ryo Kamata,Yuki Fujii,Venkat R. Chirasani,Sharon L. Campbell,Koh Takeuchi,Toshiya Senda,Atsuo T. Sasaki

DOI: https://doi.org/10.3389/fmolb.2021.707439

IF: 6.113

2021-07-08

Frontiers in Molecular Biosciences

Abstract:RAS is a founding member of the RAS superfamily of GTPases. These small 21 kDa proteins function as molecular switches to initialize signaling cascades involved in various cellular processes, including gene expression, cell growth, and differentiation. RAS is activated by GTP loading and deactivated upon GTP hydrolysis to GDP. Guanine nucleotide exchange factors (GEFs) and GTPase-activating proteins (GAPs) accelerate GTP loading and hydrolysis, respectively. These accessory proteins play a fundamental role in regulating activities of RAS superfamily small GTPase via a conserved guanine binding (G)-domain, which consists of five G motifs. The Switch regions lie within or proximal to the G2 and G3 motifs, and undergo dynamic conformational changes between the GDP-bound “OFF” state and GTP-bound “ON” state. They play an important role in the recognition of regulatory factors (GEFs and GAPs) and effectors. The G4 and G5 motifs are the focus of the present work and lie outside Switch regions. These motifs are responsible for the recognition of the guanine moiety in GTP and GDP, and contain residues that undergo post-translational modifications that underlie new mechanisms of RAS regulation. Post-translational modification within the G4 and G5 motifs activates RAS by populating the GTP-bound “ON” state, either through enhancement of intrinsic guanine nucleotide exchange or impairing GAP-mediated down-regulation. Here, we provide a comprehensive review of post-translational modifications in the RAS G4 and G5 motifs, and describe the role of these modifications in RAS activation as well as potential applications for cancer therapy.

biochemistry & molecular biology
Conditional Cooperativity in the RAS Assembly Pathway on Nanodiscs and Altered GTPase Cycling

Soo-Yeon Lee,Ki-Young Lee

DOI: https://doi.org/10.1002/anie.202316942

2024-02-03

Angewandte Chemie International Edition

Abstract:Self-assemblies (i.e., nanoclusters) of the RAS GTPase on the membrane act as scaffolds that activate downstream RAF kinases and drive MAPK signaling for cell proliferation and tumorigenesis. However, the mechanistic details of nanoclustering remain largely unknown. Here, size-tunable nanodisc platforms and paramagnetic relaxation enhancement (PRE) analyses revealed the structural basis of cooperative assembly processes of fully processed KRAS, mutated in a quarter of human cancers. The cooperativity is modulated by the mutation and nucleotide states of KRAS and the lipid composition in the membrane. Notably, the oncogenic mutants assemble in a nonsequential pathways with two mutually cooperative 'α/α' and 'α/β' interfaces, while α/α dimerization of wild-type KRAS promotes the secondary α/β interaction in a sequential manner. Mutation-based interface engineering was used to selectively trap the oligomeric intermediates of KRAS and to probe their favorable interface interactions. Transiently exposed interfaces are available for the assembly. Real-time NMR demonstrated that higher-order oligomers retain larger numbers of active GTP-bound protomers in KRAS GTPase cycling. These data provide a deeper understanding of the nanocluster-enhanced signaling in response to the environment. Furthermore, our methodology is applicable to assemblies of many other membrane GTPases and to lipid nanoparticle-based formulations of stable protein oligomers with enhanced cooperativity.

chemistry, multidisciplinary
Activation of connexin-43 hemichannels can elevate [Ca(2+)]i and [Na(+)]i in rabbit ventricular myocytes during metabolic inhibition.

F. Li,K. Sugishita,Z. Su,I. Ueda,W. Barry

DOI: https://doi.org/10.1006/JMCC.2001.1477

IF: 5.763

2001-12-01

Journal of Molecular and Cellular Cardiology

Abstract:ATP depletion due to ischemia or metabolic inhibition (MI) causes Na(+) and Ca(2+) accumulation in myocytes, which may be in part due to opening of connexin-43 hemichannels. Halothane (H) has been shown to reduce conductance of connexin-43 hemichannels and to protect the heart against ischemic injury. We therefore investigated the effect of halothane on [Ca(2+)]i and [Na(+)]i in myocytes during MI. Isolated rabbit left ventricular myocytes were loaded with 4 microM fluo-3 AM for 30 min, or with 5 microM sodium green AM for 60 min at 37 degrees C. After washing, the myocytes were exposed to: (1) Normal HEPES solution; (2) MI solution (2 mM NaCN, 20 mM 2-deoxy-D-glucose and 0-glucose); or (3) MI+H (0.95 mM, 4.7 mM) for 60 min. Propidium iodide (PI, 25 microM) was added to all samples before data acquisition. The fluorescence intensity was measured by flow cytometry with 488 nm excitation and 530 nm emission for fluo-3 or sodium green, and 670 nm for PI. The [Ca(2+)]i and [Na(+)]i were then calculated by calibration. In some experiments, the effect of 10 microM tetrodotoxin (TTX) and 20 microM nifedipine (NIF) were studied. Metabolic inhibition for 60 min caused a significant increase in [Ca(2+)]i and [Na(+)]i in myocytes when compared to controls, which was significantly reduced by halothane in a dose-dependent fashion. In the presence of TTX and NIF, halothane also significantly reduced the rise in the [Ca(2+)]i and [Na(+)]i in myocytes subjected to MI. 1-heptanol, another gap junction blocker, had similar effects. Thus, halothane reduced [Ca(2+)]i and [Na(+)]i overload produced by MI in myocytes. This effect is not solely due to block of voltage-gated Na(+) and Ca(2+) channels, and is likely mediated by inhibiting the opening of connexin-43 hemichannels.
Ras-GTP dimers activate the Mitogen-Activated Protein Kinase (MAPK) pathway

Xiaolin Nan,Tanja M. Tamgüney,Eric A. Collisson,Li-Jung Lin,Cameron Pitt,Jacqueline Galeas,Sophia Lewis,Joe W. Gray,Frank McCormick,Steven Chu

DOI: https://doi.org/10.1073/pnas.1509123112

IF: 11.1

2015-06-16

Proceedings of the National Academy of Sciences

Abstract:Significance Rat sarcoma (Ras) proteins play central roles in both normal and oncogenic signaling. Mechanisms of how Ras interacts with its effectors on the cell membrane, however, are still poorly understood, significantly hampering efforts to target this molecule in human cancer. Here we have used quantitative superresolution fluorescence microscopy in combination with carefully engineered biological systems to show that Ras dimers drive oncogenic signaling through the Raf-MAPK pathway. Our study suggests a new, dimer model of Ras-Raf signaling and the potential value of Ras dimers as a therapeutic target.
RAS oncogenes: weaving a tumorigenic web

Yuliya Pylayeva-Gupta,Elda Grabocka,Dafna Bar-Sagi

DOI: https://doi.org/10.1038/nrc3106

IF: 78.5

2011-10-13

Nature Reviews Cancer

Abstract:Key PointsRAS is a GTPase that is frequently mutated in cancer and that affects a variety of cancer-driving processes. Unique properties of RAS isoforms, and of particular activating mutations, may distinctly affect the process of neoplastic conversion in different tissues.RAS drives cellular proliferation by providing both cell-autonomous and non-cell-autonomous cues, which ultimately converge in the transformed cells to promote pro-growth and to inhibit anti-growth signals. RAS-mediated proliferative overdrive may induce replicative stress and activation of DNA damage responses.The suppression of a cell death response by oncogenic RAS is a consequence of a perturbation of homeostatic balance between pro-apoptotic and anti-apoptotic signals. To keep up with the high energy needs of growing cells, the survival of RAS-transformed cells is further aided by metabolic reprogramming towards glycolysis that is mediated by MAPK- and PI3K-dependent regulation of hypoxia-inducible factor 1α (HIF1α).Oncogenic RAS modulates the tumour microenvironment by promoting pro-angiogenic mechanisms and by altering host-mediated immune responses. Transformation by RAS can also promote changes in motility and cellular adhesion, leading to the acquisition of invasive and metastatic properties of cancer cells.Breakthroughs in real-time imaging, computational approaches, high-throughput screening and genetically engineered mouse modelling promise to advance our capacity to integrate the complexity of RAS signalling pathways with the context specificity of their oncogenic activities, undoubtedly aiding the implementation of successful remedial strategies in the clinic.

oncology
Understanding the Molecular Mechanism of PLCε Regulation and G Protein‐Mediated Activation

Kaushik Muralidharan,Rachel Tat,Kennedy Outlaw,Vaani Ohri,Hannah Flaherty,Elisabeth Garland‐Kuntz,Angeline Lyon

DOI: https://doi.org/10.1096/fasebj.2022.36.s1.r3903

2022-05-01

The FASEB Journal

Abstract:Cardiovascular disease is the leading cause of death in the world. The phospholipase C (PLC) family of enzymes, in particular the PLCε subfamily, are essential for normal cardiovascular function. PLCε hydrolyzes phosphatidylinositol phosphates at cellular membranes, producing inositol phosphates (IPx) and diacylglycerol (DAG). These crucial secondary messengers activate multiple downstream pathways, including cardiac contractility and the expression of hypertrophic genes. In the cardiovascular system, PLCε is regulated through direct interactions with the RhoA and Rap1A small GTPases, which in turn are activated downstream of G protein‐coupled receptors (GPCRs). RhoA is reported to activate PLCε at the plasma membrane, whereas Rap1A translocates and activates PLCε at the perinuclear membrane. However, the elements within PLCε that regulate basal activity and membrane association have not been fully identified. Similarly, the domains involved in Rap1A versus RhoA binding, activation and translocation to different subcellular membranes have not been mapped. In this work, we use a structure‐guided approach, together with cell‐based activity assays, epifluorescence, and confocal microscopy to identify the roles of PLCε regulatory elements and domains in basal activity, subcellular localization, and regulation by RhoA and Rap1A GTPases. Functional studies show N‐ and C‐terminal regulatory domains of PLCε dictate its location within the cell, and contribute differently to basal and G protein‐dependent activity. We also show that regulatory insertions within the catalytic TIM barrel, including the X–Y linker and Y‐box, aid in interfacial activation and membrane association. These studies provide much needed insights into the molecular determinants of PLCε that regulate its localization and activity in cells, which is critical for elucidating its roles in cardiovascular function.

cell biology,biochemistry & molecular biology,biology
Complex interplay between RAS GTPases and RASSF effectors regulates subcellular localization of YAP

Swati Singh,Gabriela Bernal Astrain,Ana Maria Hincapie,Marilyn Goudreault,Matthew J Smith

DOI: https://doi.org/10.1038/s44319-024-00203-9

Abstract:RAS GTPases bind effectors to convert upstream cues to changes in cellular function. Effectors of classical H/K/NRAS are defined by RBD/RA domains which recognize the GTP-bound conformation of these GTPases, yet the specificity of RBD/RAs for over 160 RAS superfamily proteins remains poorly explored. We have systematically mapped interactions between BRAF and four RASSF effectors, the largest family of RA-containing proteins, with all RAS, RHO and ARF small GTPases. 39 validated complexes reveal plasticity in RASSF binding, while BRAF demonstrates tight specificity for classical H/K/NRAS. Complex between RASSF5 and diverse RAS GTPases at the plasma membrane can activate Hippo signalling and sequester YAP in the cytosol. RASSF8 undergoes liquid-liquid phase separation and resides in YAP-associated membraneless condensates, which also engage several RAS and RHO GTPases. The poorly studied RASSF3 has been identified as a first potential effector of mitochondrial MIRO proteins, and its co-expression with these GTPases impacts mitochondria and peroxisome distribution. These data reveal the complex nature of GTPase-effector interactions and show their systematic elucidation can reveal completely novel and biologically relevant cellular processes.
RAS Proteins and Their Regulators in Human Disease

Dhirendra K. Simanshu,Dwight V. Nissley,Frank McCormick

DOI: https://doi.org/10.1016/j.cell.2017.06.009

IF: 64.5

2017-06-01

Cell

Abstract:RAS proteins are binary switches, cycling between ON and OFF states during signal transduction. These switches are normally tightly controlled, but in RAS-related diseases, such as cancer, RASopathies, and many psychiatric disorders, mutations in the RAS genes or their regulators render RAS proteins persistently active. The structural basis of the switch and many of the pathways that RAS controls are well known, but the precise mechanisms by which RAS proteins function are less clear. All RAS biology occurs in membranes: a precise understanding of RAS' interaction with membranes is essential to understand RAS action and to intervene in RAS-driven diseases.

cell biology,biochemistry & molecular biology
Conformational Features of Ras: Key Hydrogen-Bonding Interactions of GIn61 in the Intermediate State during GTP Hydrolysis

Juan Zeng,Jingwei Weng,Yuwei Zhang,Fei Xia,Qiang Cui,Xin Xu

DOI: https://doi.org/10.1021/acs.jpcb.1c04679

2021-01-01

Abstract:The Ras protein is one of the most important drug targets for battling cancers. To effectively design novel drugs of Ras, we characterize here its conformational ensembles for the hydrolysis intermediate state RasGDP.Pi and the product state RasGDP by extensive replica-exchange molecular dynamics simulations. Several substates for RasGDP.Pi have been identified, while structural analyses have revealed an unrecognized hydrogen-bonding network that stabilizes the hydrolysis intermediate state. More interestingly, Gln61, which is involved in numerous oncogenic mutations, was found to be engaged in this hydrogen-bonding network, adopting a specific conformation that always points to Pi in contrast to that in the RasGTP state. The simulations also reveal that RasGDP has more than one substate, suggesting a conformational selection mechanism for the interaction between Ras and the guanine nucleotide exchange factors (GEFs). These findings offer new opportunities for the drug design of Ras by stabilizing the hydrolysis intermediate or disrupting its interaction with the GEFs.
RAL GTPases: Biology and Potential As Therapeutic Targets in Cancer

Chao Yan,Dan Theodorescu

DOI: https://doi.org/10.1124/pr.117.014415

2018-01-01

Pharmacological Reviews

Abstract:More than a hundred proteins comprise the RAS superfamily of small GTPases. This family can be divided into RAS, RHO, RAB, RAN, ARF, and RAD subfamilies, with each shown to play distinct roles in human cells in both health and disease. The RAS subfamily has a well-established role in human cancer with the three genes, HRAS, KRAS, and NRAS being the commonly mutated in tumors. These RAS mutations, most often functionally activating, are especially common in pancreatic, lung, and colorectal cancers. Efforts to inhibit RAS and related GTPases have produced inhibitors targeting the downstream effectors of RAS signaling, including inhibitors of the RAF-mitogen-activated protein kinase/extracellular signal-related kinase (ERK)-ERK kinase pathway and the phosphoinositide-3-kinase-AKT-mTOR kinase pathway. A third effector arm of RAS signaling, mediated by RAL (RAS like) has emerged in recent years as a critical driver of RAS oncogenic signaling and has not been targeted until recently. RAL belongs to the RAS branch of the RAS superfamily and shares a high structural similarity with RAS. In human cells, there are two genes, RALA and RALB, both of which have been shown to play roles in the proliferation, survival, and metastasis of a variety of human cancers, including lung, colon, pancreatic, prostate, skin, and bladder cancers. In this review, we summarize the latest knowledge of RAL in the context of human cancer and the recent advancements in the development of cancer therapeutics targeting RAL small GTPases.
Experimental variables determine the outcome of RAS-RAS interactions

Zhiwei Zhou,Tra Ly Nguyen,Xingxiao Li,Christel Poujol,Ewa Berlinska,Sandra Vietti Michelina,Jonas N Kapp,Andreas Plückthun,Monte M Winslow,Chiara Ambrogio,Yibing Shan,David Santamaría,Kenneth D Westover

DOI: https://doi.org/10.1016/j.jbc.2024.107859

Abstract:RAS clustering at the cell membrane is critical to activate signaling in cells, but whether this clustering is mediated exclusively by its c-terminal hypervariable region, receives contributions from the G-domain of RAS, and/or is influenced by secondary effectors has been intensely debated. Reports that G-domain mutations do not modulate RAS-RAS interactions have led some to question the validity of previous experiments that indicate the G-domain plays a role in RAS clustering/interactions. Here we reconcile these findings by clarifying the impact of experimental variables, such as protein expression levels, cellular context, RAS zygosity, and secondary effector interactions on RAS clustering. Lack of control over these variables impacts the results using G-domain mutations across various assay systems and can lead to unsound conclusions.
One Step Closer to Targeting RAS.

Chao Yan,Dan Theodorescu

DOI: https://doi.org/10.1080/15384101.2015.1006534

2015-01-01

Abstract:The RAS family of small GTPases play critical roles in many types of human cancer. Activating RAS mutations are the most frequent type of oncogene mutations in human cancers, and are especially common in pancreatic, lung, and colorectal cancer. However, failure to obtain clinically useful inhibitors for RAS or any other GTPases suggests this target family is a therapeutic challenge. Consequently, significant efforts have been shifted toward targeting of downstream effectors of RAS including the Raf-MEK-ERK kinase pathway and the PI3K-AKT-mTOR kinase pathway. A third arm of RAS effector signaling, RAL (Ras-like) has not been targeted until recently and like RAS, is activated, but unlike RAS is not commonly mutated in cancer. RAL also shares a high structure similarity with RAS and other GTPase of the RAS superfamily. The two isoforms RALA and RALB are both important drivers of the proliferation, survival and metastasis of multiple human cancers. In our recent publication we reported the discovery of small molecule inhibitors of RAL.1
Targeting RAS mutants in malignancies: successes, failures, and reasons for hope

Hang Yang,Xinyi Zhou,Dongliang Fu,Chenqin Le,Jiafeng Wang,Quan Zhou,Xiangrui Liu,Ying Yuan,Kefeng Ding,Qian Xiao

DOI: https://doi.org/10.1002/cac2.12377

IF: 15.2825

2023-01-01

Cancer Communications

Abstract:RAS genes are the most frequently mutated oncogenes and play critical roles in the development and progression of malignancies. The mutation, isoform (KRAS, HRAS, and NRAS), position, and type of substitution vary depending on the tissue types. Despite decades of developing RAS-targeted therapies, only small subsets of these inhibitors are clinically effective, such as the allele-specific inhibitors against KRASG12C. Targeting the remaining RAS mutants would require further experimental elucidation ofRAS signal transduction, RAS-altered metabolism, and the associated immune microenvironment. This study reviews the mechanisms and efficacy of novel targeted therapies for different RAS mutants, including KRAS allele-specific inhibitors, combination therapies, immunotherapies, and metabolism-associated therapies.

Diagnosis and treatment of common urinary tract infections.

RAS G-domains Fine-Tune the Sorting of Phosphatidylserine Acyl Chains in the Plasma Membrane

RAS G-domains allosterically contribute to the recognition of lipid headgroups and acyl chains

Implications for Downstream Signaling

Ras signaling mechanisms: New insights from single-molecule biophysics

K-Ras G-domain binding with signaling lipid phosphatidylinositol (4,5)-phosphate (PIP2): membrane association, protein orientation, and function

Abstract A015: Dynamics and lipid interactions of the RAS-RBD-CRD protein complex

Biophysical mechanism for Ras-nanocluster formation and signaling in plasma membrane

Divergent Mechanisms Activating RAS and Small GTPases Through Post-translational Modification

Conditional Cooperativity in the RAS Assembly Pathway on Nanodiscs and Altered GTPase Cycling

Activation of connexin-43 hemichannels can elevate [Ca(2+)]i and [Na(+)]i in rabbit ventricular myocytes during metabolic inhibition.

Ras-GTP dimers activate the Mitogen-Activated Protein Kinase (MAPK) pathway

RAS oncogenes: weaving a tumorigenic web

Understanding the Molecular Mechanism of PLCε Regulation and G Protein‐Mediated Activation

Complex interplay between RAS GTPases and RASSF effectors regulates subcellular localization of YAP

RAS Proteins and Their Regulators in Human Disease

Conformational Features of Ras: Key Hydrogen-Bonding Interactions of GIn61 in the Intermediate State during GTP Hydrolysis

RAL GTPases: Biology and Potential As Therapeutic Targets in Cancer

Experimental variables determine the outcome of RAS-RAS interactions

One Step Closer to Targeting RAS.

Targeting RAS mutants in malignancies: successes, failures, and reasons for hope